A growing number of studies supported 5‐HT receptors as the targets for improving cognitive dysfunction in AD, including 5‐HT1BR, 5‐HT1DR, and 5‐HT6R (Rodríguez et al., 2012). The gene discussed is HTR6; the disease is Alzheimer disease.